1-cyclohexyl-2-[4-[[4-[(4-methylphenyl)sulfonylamino]phenyl]carbamoyl]phenyl]benzimidazole-5-carboxylic acid

C34H32N4O5S — CID 23515608

IUPAC1-cyclohexyl-2-[4-[[4-[(4-methylphenyl)sulfonylamino]phenyl]carbamoyl]phenyl]benzimidazole-5-carboxylic acid
SMILESCc1ccc(S(=O)(=O)Nc2ccc(NC(=O)c3ccc(-c4nc5cc(C(=O)O)ccc5n4C4CCCCC4)cc3)cc2)cc1
InChIInChI=1S/C34H32N4O5S/c1-22-7-18-29(19-8-22)44(42,43)37-27-16-14-26(15-17-27)35-33(39)24-11-9-23(10-12-24)32-36-30-21-25(34(40)41)13-20-31(30)38(32)28-5-3-2-4-6-28/h7-21,28,37H,2-6H2,1H3,(H,35,39)(H,40,41)
InChIKeyZGGVMFWYZHFFJV-UHFFFAOYSA-N
MW608.72 g/mol
LogP7.27
Rot. Bonds8

About 1-cyclohexyl-2-[4-[[4-[(4-methylphenyl)sulfonylamino]phenyl]carbamoyl]phenyl]benzimidazole-5-carboxylic acid

1-cyclohexyl-2-[4-[[4-[(4-methylphenyl)sulfonylamino]phenyl]carbamoyl]phenyl]benzimidazole-5-carboxylic acid (PubChem CID 23515608) has the molecular formula C34H32N4O5S and a molecular weight of 608.72 g/mol. Its IUPAC name is 1-cyclohexyl-2-[4-[[4-[(4-methylphenyl)sulfonylamino]phenyl]carbamoyl]phenyl]benzimidazole-5-carboxylic acid.

Molecular Properties

Compound Name1-cyclohexyl-2-[4-[[4-[(4-methylphenyl)sulfonylamino]phenyl]carbamoyl]phenyl]benzimidazole-5-carboxylic acid
PubChem CID23515608
Molecular FormulaC34H32N4O5S
Molecular Weight608.72 g/mol
Exact Mass608.21
IUPAC Name1-cyclohexyl-2-[4-[[4-[(4-methylphenyl)sulfonylamino]phenyl]carbamoyl]phenyl]benzimidazole-5-carboxylic acid
SMILESCc1ccc(S(=O)(=O)Nc2ccc(NC(=O)c3ccc(-c4nc5cc(C(=O)O)ccc5n4C4CCCCC4)cc3)cc2)cc1
InChIInChI=1S/C34H32N4O5S/c1-22-7-18-29(19-8-22)44(42,43)37-27-16-14-26(15-17-27)35-33(39)24-11-9-23(10-12-24)32-36-30-21-25(34(40)41)13-20-31(30)38(32)28-5-3-2-4-6-28/h7-21,28,37H,2-6H2,1H3,(H,35,39)(H,40,41)
InChIKeyZGGVMFWYZHFFJV-UHFFFAOYSA-N
XLogP7.27
TPSA130.39 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms44
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500608.72
LogP ≤ 57.27
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Analyze 1-cyclohexyl-2-[4-[[4-[(4-methylphenyl)sulfonylamino]phenyl]carbamoyl]phenyl]benzimidazole-5-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-cyclohexyl-2-[4-[[4-[(4-methylphenyl)sulfonylamino]phenyl]carbamoyl]phenyl]benzimidazole-5-carboxylic acid?
The IUPAC name of 1-cyclohexyl-2-[4-[[4-[(4-methylphenyl)sulfonylamino]phenyl]carbamoyl]phenyl]benzimidazole-5-carboxylic acid (CID 23515608) is 1-cyclohexyl-2-[4-[[4-[(4-methylphenyl)sulfonylamino]phenyl]carbamoyl]phenyl]benzimidazole-5-carboxylic acid.
What is the SMILES notation for 1-cyclohexyl-2-[4-[[4-[(4-methylphenyl)sulfonylamino]phenyl]carbamoyl]phenyl]benzimidazole-5-carboxylic acid?
The canonical SMILES for 1-cyclohexyl-2-[4-[[4-[(4-methylphenyl)sulfonylamino]phenyl]carbamoyl]phenyl]benzimidazole-5-carboxylic acid is Cc1ccc(S(=O)(=O)Nc2ccc(NC(=O)c3ccc(-c4nc5cc(C(=O)O)ccc5n4C4CCCCC4)cc3)cc2)cc1.
What is the InChIKey of 1-cyclohexyl-2-[4-[[4-[(4-methylphenyl)sulfonylamino]phenyl]carbamoyl]phenyl]benzimidazole-5-carboxylic acid?
The InChIKey is ZGGVMFWYZHFFJV-UHFFFAOYSA-N. The full InChI is InChI=1S/C34H32N4O5S/c1-22-7-18-29(19-8-22)44(42,43)37-27-16-14-26(15-17-27)35-33(39)24-11-9-23(10-12-24)32-36-30-21-25(34(40)41)13-20-31(30)38(32)28-5-3-2-4-6-28/h7-21,28,37H,2-6H2,1H3,(H,35,39)(H,40,41).
What are the key properties of 1-cyclohexyl-2-[4-[[4-[(4-methylphenyl)sulfonylamino]phenyl]carbamoyl]phenyl]benzimidazole-5-carboxylic acid?
1-cyclohexyl-2-[4-[[4-[(4-methylphenyl)sulfonylamino]phenyl]carbamoyl]phenyl]benzimidazole-5-carboxylic acid has a molecular weight of 608.72 g/mol, XLogP of 7.27, 8 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 1-cyclohexyl-2-[4-[[4-[(4-methylphenyl)sulfonylamino]phenyl]carbamoyl]phenyl]benzimidazole-5-carboxylic acid is sourced from PubChem (CID 23515608), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).